← boardnext 2026-11
MCUJF
Medicuredistress 1/10 · well-funded / low risk$0.840%today-12% from 52w high
Lead: Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Revenue
pre-revenue
Liquidity
$2M
Runway
2.8 yrs
Shares 1y
0%
Price & events
-10.6% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+25.4%
1W
+25.4%
1M
-12.5%
3M
-10.6%
6M
+3.7%
1Y
+13.5%
2Y
-13.4%
5Y
-12.5%
All
Overview
- Market Cap
- $8.77M
- Volume
- 200
- 52 Week Range
- $0.67 – $0.96
- Total Shares
- 10.44M
- Float Shares
- 5.27M
- % Held by Insiders
- 27.30%
- % Held by Institutions
- 23.10%
- RVOL
- 0.47x
- Beta
- 1.04
Pipeline stages · 1 programs
Pyridoxal Phosphate
Preclin›
Ph1›
Ph2›
Ph3›
Filed›
PDUFA›
Approved
Pipeline · 1 trials · 1 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| 2026-11 Estimated 50% readout ~2027-01-15 | Phase 3 | Pyridoxal Phosphate | Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency | — | recruiting |
Catalyst news & presentations · 1
- 2026-08-19Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (3)
- ZYPITAMAGPITAVASTATIN MAGNESIUM2017 · Prescription
- AGGRASTATTIROFIBAN HYDROCHLORIDE1998 · Prescription
- AGGRASTATTIROFIBAN HYDROCHLORIDE1998 · Prescription
Capital structure — dilution & financing
Shares out: 10,436,313 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors — Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
- none identified
Recent news
- 2026-07-07Medicure CFO Haaris Uddin resigns; James Kinley appointed interim CFO - MSN
- 2026-07-03Medicure Announces CFO Change - Yahoo Finance
- 2026-07-03Medicure CFO change: Uddin exits July 24, Kinley steps in - Stock Titan
- 2026-06-30Price to earnings forward of Medicure Inc. – TSXV:MPH - TradingView
- 2026-05-21Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call - Yahoo Finance
- 2026-04-17Medicure Announces Resignation of President and Chief Operating Officer - Yahoo Finance
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.